Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

(4S)-4-(3-[18F]Fluoropropyl)-L-glutamate Radiotracer (FSPG) PET/CT for Imaging xC- Transporter Activity in Cancers

NCT03144622 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT03144622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03144622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
(4S)-4-(3-[18F]Fluoropropyl)-L-glutamate Radiotracer (FSPG) PET/CT for Imaging xC- Transporter Activity in Cancers
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 6, 2016
Completion date
December 31, 2022
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal cancer, breast neoplasms, pulmonary cancer